Advertisement
BD Biosciences
BD Biosciences

Most Recent

image: Neglected Babies Develop Less Myelin

Neglected Babies Develop Less Myelin

By | September 17, 2012

Mice raised in isolation from their mothers developed cognitive deficits similar to those of babies raised in orphanages where physical contact is infrequent.

2 Comments

image: Double-Edged TB Drug

Double-Edged TB Drug

By | September 12, 2012

A cheap pain reliever that can kill drug-resistant, tuberculosis-causing bacteria may never be tested.

2 Comments

image: Fears over Fast-Tracking Drugs

Fears over Fast-Tracking Drugs

By | September 10, 2012

Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.

0 Comments

image: Rethinking Herbal Medicine

Rethinking Herbal Medicine

By | September 10, 2012

A phylogenetic study of traditional plant remedies could aid drug development.

21 Comments

image: Finding Injury

Finding Injury

By | September 1, 2012

The brain’s phagocytes follow an ATP bread trail laid down by calcium waves to the site of damage.

0 Comments

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

image: Orphan Drugs Lucrative

Orphan Drugs Lucrative

By | August 24, 2012

The market for drugs that target rare diseases is expected to rival big pharma blockbusters in the coming decades.

1 Comment

image: Hope for Male Contraception

Hope for Male Contraception

By | August 16, 2012

A small molecule that inhibits a protein important for chromatin organization can cause reversible sterility in male mice.

0 Comments

image: Pharma Whistleblower

Pharma Whistleblower

By | August 16, 2012

A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.

1 Comment

image: Pharma's Fake Innovation Crisis?

Pharma's Fake Innovation Crisis?

By | August 13, 2012

Two medical professors contend that the pharmaceutical industry is really suffering from a drive to make only marginal improvements to existing drugs.

2 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
BD Biosciences
BD Biosciences

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
Advertisement
Molecular Devices
Molecular Devices
Life Technologies